[PHAT] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
14-Jun-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -84.01%
YoY- -25.40%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 16,352 7,324 1,912 682 0 0 0 -
PBT -85,577 -91,446 -82,852 -79,570 -43,243 -40,965 -37,814 72.11%
Tax 0 0 171 -16,738 7,266 9,618 -146 -
NP -85,577 -91,446 -82,852 -79,570 -43,243 -40,965 -37,668 72.56%
Tax Rate - - - - - - - -
Total Cost 101,929 98,770 84,764 80,252 43,243 40,965 37,668 93.83%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -523.34 -1,248.58 -4,333.26 -11,667.16 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.32 -1.56 -1.42 -1.39 -0.76 -0.84 -0.89 29.96%
EPS Diluted -1.32 -1.56 -1.42 -1.39 -0.76 -0.84 -0.89 29.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.